Source: International Congress 2015 – Emerging strategies for airway disease treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
John Upham (Brisbane, Australia), John Upham, Megan Landgraf, Camilla Xi. LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors. Eur Respir J 2015; 46: Suppl. 59, 4369

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Immunology indices in severe bronchial asthma with different levels of disease control in children Source: Annual Congress 2013 –Asthma Year: 2013 LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 TSLP as biomarker in asthma patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015